Search research articles
Contact Us
Filters
Showing results (31-40 of 70) with videos related to
Page
of 7
Sort By:
Leukemia Research
|
September 28, 2023
TET2 somatic copy number alterations and allelic imbalances in chronic myelomonocytic leukemia
Mark Gurney, Patricia T Greipp, Troy Gliem, et al.
American Journal of Hematology
|
January 22, 2013
Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevance
Mrinal M Patnaik, Terra L Lasho, Christy M Finke, et al.
Leukemia
|
May 2, 2018
A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone
Mrinal M Patnaik, Rangit Vallapureddy, Terra L Lasho, et al.
Haematologica
|
January 5, 2019
Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the <i>JAK2</i>V617F mutation
Mrinal M Patnaik, Prateek A Pophali, Terra L Lasho, et al.
American Journal of Hematology
|
December 24, 2017
JAK2 exon 12 mutated polycythemia vera: Mayo-Careggi MPN Alliance study of 33 consecutive cases and comparison with JAK2V617F mutated disease
Ayalew Tefferi, Sravanthi Lavu, Mythri Mudireddy, et al.
American Journal of Hematology
|
September 9, 2014
Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic-French Consortium Study
Emnet A Wassie, Raphael Itzykson, Terra L Lasho, et al.
Leukemia Research
|
November 10, 2019
Functional evaluation of isocitrate dehydrogenase 1 and 2 variants of unclear significance in chronic myeloid neoplasms
Alexander Tischer, Guadalupe Antelo, Giacomo Coltro, et al.
American Journal of Hematology
|
February 9, 2018
Mutations and prognosis in myelodysplastic syndromes: karyotype-adjusted analysis of targeted sequencing in 300 consecutive cases and development of a genetic risk model
Naseema Gangat, Mythri Mudireddy, Terra L Lasho, et al.
Blood Advances
|
February 23, 2018
Targeted next-generation sequencing in blast phase myeloproliferative neoplasms
Terra L Lasho, Mythri Mudireddy, Christy M Finke, et al.
Blood Cancer Journal
|
January 27, 2019
Leukemic transformation among 1306 patients with primary myelofibrosis: risk factors and development of a predictive model
Rangit R Vallapureddy, Mythri Mudireddy, Domenico Penna, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 70) with videos related to
Sort By:
Page
of 7
Leukemia Research
|
September 28, 2023
TET2 somatic copy number alterations and allelic imbalances in chronic myelomonocytic leukemia
Mark Gurney, Patricia T Greipp, Troy Gliem, et al.
American Journal of Hematology
|
January 22, 2013
Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevance
Mrinal M Patnaik, Terra L Lasho, Christy M Finke, et al.
Leukemia
|
May 2, 2018
A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone
Mrinal M Patnaik, Rangit Vallapureddy, Terra L Lasho, et al.
Haematologica
|
January 5, 2019
Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the <i>JAK2</i>V617F mutation
Mrinal M Patnaik, Prateek A Pophali, Terra L Lasho, et al.
American Journal of Hematology
|
December 24, 2017
JAK2 exon 12 mutated polycythemia vera: Mayo-Careggi MPN Alliance study of 33 consecutive cases and comparison with JAK2V617F mutated disease
Ayalew Tefferi, Sravanthi Lavu, Mythri Mudireddy, et al.
American Journal of Hematology
|
September 9, 2014
Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic-French Consortium Study
Emnet A Wassie, Raphael Itzykson, Terra L Lasho, et al.
Leukemia Research
|
November 10, 2019
Functional evaluation of isocitrate dehydrogenase 1 and 2 variants of unclear significance in chronic myeloid neoplasms
Alexander Tischer, Guadalupe Antelo, Giacomo Coltro, et al.
American Journal of Hematology
|
February 9, 2018
Mutations and prognosis in myelodysplastic syndromes: karyotype-adjusted analysis of targeted sequencing in 300 consecutive cases and development of a genetic risk model
Naseema Gangat, Mythri Mudireddy, Terra L Lasho, et al.
Blood Advances
|
February 23, 2018
Targeted next-generation sequencing in blast phase myeloproliferative neoplasms
Terra L Lasho, Mythri Mudireddy, Christy M Finke, et al.
Blood Cancer Journal
|
January 27, 2019
Leukemic transformation among 1306 patients with primary myelofibrosis: risk factors and development of a predictive model
Rangit R Vallapureddy, Mythri Mudireddy, Domenico Penna, et al.
Page
of 7